Within our areas of focus, we build on a deep understanding of biology and unmet patient needs to pursue solutions that will elevate the standard of care for a number of diseases and conditions.
We focus on a core set of therapeutic areas - ones where we've proven our expertise and where we have even greater potential to improve how diseases and conditions are managed. These include oncology, immunology, neuroscience, eye care and aesthetics.
We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and offer solutions for more diverse patient populations.
We leverage our deep understanding of human biology and cutting-edge research technologies to find new ways to make a difference to the lives of people with cancer. Building on the scientific discoveries we have made in blood cancer, we are now expanding our knowledge to investigate solid tumors.
Our scientists are relentless in their pursuit of raising the standards of care for neurological diseases and disorders. We are exploring innovative, disease-modifying solutions to address some of the most prevalent and serious disorders, from Parkinson's, Alzheimer's and broader movement disorders to schizophrenia, migraine and stroke.
Driven by the ambition to maintain vision and prevent blindness our work is focused on improving the standards of care across multiple disease areas from the front to the back of the eye, from glaucoma to chronic retinal diseases.
We create products and technologies that advance aesthetic medicine. Our aesthetics R&D team seeks to discover and accelerate comprehensive, evidence-based solutions focused on novel indications, improved delivery technologies and enhanced patient outcomes.
UK-ABBV-260028 | February 2026
You are now leaving the AbbVie UK website. The website you’re visiting is not subject to the AbbVie Privacy Policy, and AbbVie is not responsible for, nor does it endorse content on this third-party site.